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ChIP-seq is an established manually-performed method for identifying DNA-protein interactions genome-wide.
Here, we describe a protocol for automated high-throughput (AHT) ChIP-seq. To demonstrate the quality of data
obtained using AHT-ChIP-seq, we applied it to five proteins in mouse livers using a single 96-well plate, demonstrating
an extremely high degree of qualitative and quantitative reproducibility among biological and technical replicates. We
estimated the optimum and minimum recommended cell numbers required to perform AHT-ChIP-seq by running an
additional plate using HepG2 and MCF7 cells. With this protocol, commercially available robotics can perform four
hundred experiments in five days.Background
The ability to decipher regulatory information held in the
genome and epigenome is essential to understanding how
transcription is controlled or perturbed through natural
genetic variation and in diseased states. Chromatin immu-
noprecipitation followed by high throughput sequencing
(ChIP-seq) has become a widely used method to identify
regulatory DNA sequence directly occupied by transcrip-
tion factors, basal transcriptional machinery, and specific-
ally covalently modified histones.
Previous large-scale ChIP studies required enormous
manual experiments or large consortia. Genome-wide data
sets for epigenetic information have demonstrated the
role of chromatin organization in genome function in
single cell types [1-3]. These chromatin maps display his-
tone modifications that demarcate different regulatory
regions of the genome such as promoters and gene bodies,
or regulatory states such as active or repressed transcrip-
tion. By contrast, to achieve the scale required for the
ENCODE consortia, performing approximately 2,100 ChIP
experiments required contributions from nine laboratories* Correspondence: duncan.odom@cruk.cam.ac.uk
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reproduction in any medium, provided the orto profile the DNA binding patterns from numerous factors
and multiple cell types [4]. Further research into how this
epigenetic layer of information correlates with genotype
and phenotype will require hundreds to thousands more
protein-DNA binding assays in diverse cell types and/or
temporal studies during cell development [5-7].
A recent study implemented semi-automated analysis
of multiple transcription factors and epigenetic marks
in the transcriptional regulatory networks of a single
immune cell type during pathogen response [8]. The
powerful method developed in that study [9] permitted
characterization of 400 different protein-DNA binding
interactions genome-wide, and demonstrated the increase
in productivity that would be unlocked by developing
completely automated protocols to minimize manual
intervention and maximize throughput. Indeed, this land-
mark study would be the first of many, if ChIP experi-
ments could be fully automated.
The scale afforded by full automation of ChIP experi-
ments would enable disease genomics in patient cohorts
that could connect genotype with cellular phenotype. For
example, single nucleotide polymorphisms and small gen-
etic aberrations found in natural human genetic variation
have been shown to effect transcription factor binding
and transcription itself in studies using ChIP-seq [10].
The ability to map at high resolution targets within thel Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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driver of cell growth in breast cancer, in individual
tumors has demonstrated the link between a DNA bind-
ing protein, its effect on gene regulation, and disease
outcome [11].
Finally, the ability to map hundreds of protein-DNA
contacts genome-wide in a rapid, reproducible, and fully
automated manner would revolutionize the scale and
power of interspecies comparisons of transcription factor
binding and epigenetics [12,13]. Prior studies have been
typically restricted to three to five species of protein-DNA
data [14], which have been painstakingly collected using
manual ChIP experiments; indeed, the standard ChIP-seq
protocol performed in our laboratory, detailed in [15], is
laborious. Combined with the increasing number of refer-
ence genomes and ChIP-validated antibodies, full ChIP
automation could reveal the evolution of combinatorial
networks of tissue-specific transcription factors, chroma-
tin state, RNA polymerase binding, and RNA transcription
across potentially hundreds of mammalian species.
Here, we report a fully automated high-throughput
ChIP-seq (AHT-ChIP-seq) robotics protocol that starts
with sonicated chromatin and ends at multiplexed Illumina
DNA library preparation. We comprehensively com-
pared the robotic ChIP experiments against CEBPA, a
tissue-specific transcription factor, in a well-studied mam-
malian tissue (mouse liver) to manually obtain protein-
DNA mapping experiments. We further demonstrate
automated profiling of the genome-wide occupancy of
an additional tissue-specific transcription factor (HNF4A),
trimethylation of H3K4, RAD21 (a cohesin subunit), and
the transcriptional co-activator p300 in liver. Finally, we
estimate the minimum and optimal cell numbers a typical
ChIP experiment on the plate would require by profiling
trimethylation of H3K4 in titrated cell numbers of HepG2
and MCF7 cells, both of which are widely used human
cancer models.
Results and discussion
Scaling-down ChIP to a 96-well automatable format
We first carried out a series of experiments to optimize
the volumes of both input chromatin and antibodies, and
eliminate chemically noxious steps employed by standard
protocols [15]. For development and evaluation purposes,
we utilized the well-characterized liver transcription factor
CEBPA as a benchmark [14], because our laboratory
primarily uses liver as a model system for interspecies
comparisons of ChIP experiments.
A traditional manual experiment for isolating DNA
bound to the transcription factor CEBPA would use
one-third of an adult mouse liver (well in excess of 100
million cells), 10 μg of antibody bound to 100 μl of
Protein G magnetic beads, in a 3 ml hybridization vol-
ume. Operating a high-throughput method based aroundmouse liver would increase animal requirements signifi-
cantly: based on our current laboratory protocol, 32 mouse
livers would be needed to perform 96 ChIP experiments.
First, we established that CEBPA ChIP could be per-
formed using one-sixteenth of a mouse liver in a 200 μl
lysis buffer volume using quantitative PCR (Figure S1 in
Additional file 1). Using this standard, six mouse livers
would suffice to perform 96 ChIP experiments. Anti-
bodies represent a significant proportion of the cost when
performing a high-throughput experiment. We therefore
tested the affect of antibody concentration on the CEBPA
ChIP enrichment. We determined that 2.5 μg of CEBPA
antibody when combined with one-sixteenth of an adult
mouse liver produced adequate ChIP-seq enrichment
(Figure S1 in Additional file 1). Although we expect our
guideline amounts will be largely adaptable to typical
mammalian ChIP experiments, other specialized ChIP
experiments may well require additional optimization of
antibodies and cell/tissue quantities.
A phenol-chloroform step has been used to isolate DNA
specifically in the final stages of the ChIP reaction. Phenol-
chloroform is toxic, corrosive, and thus not ideally suited
to unventilated liquid handling robots. We substituted
this step with an Ampure XP magnetic beads purifica-
tion protocol (Beckman Coulter Ltd, High Wycombe,
UK) without detriment to the amount of DNA isolated,
as per [8,9]. This scaled-down and automation-ready
method was then programmed to run on the Agilent
NGS Workstation software (Agilent Technologies UK
Ltd, Wokingham, UK) as a five-step process (see
Materials and Methods). One of the key benefits of
automating the workflow was the ability to finely and re-
producibly control the liquid handling steps with mini-
mized sample loss at every stage. During development,
the pipetting steps were adjusted to meet the following
criteria:
1. Produce a homogeneous suspension of magnetic
beads through mixing
2. Remove all supernatant without disturbing Protein
G beads or Ampure beads whilst plate on a magnet
3. Transfer volumes precisely
4. Mix RIPA solution without foaming.
These goals were achieved by adjusting the position of
the pipette tip in the well, the velocity and acceleration
of the pipette tip into and out of the liquid, and the
velocity and acceleration of the syringe plunger. In
Additional file 2, we detail each step that was opti-
mized, with the final settings used in the automated
protocol. Additional file 3 contains all the files required
in order to run the automated protocol on an Agilent
Bravo. Automation of the protocol resulted in less user
hands-on time and a significant increase in throughput
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file 1: Figure S2).
Evaluation of AHT-ChIP-seq and comparison with
manual ChIP-seq
To demonstrate the quality and type of data a typical
user could obtain from the AHT-ChIP-seq platform, we
dissected a set of simultaneously performed ChIP-seq
experiments, including both technical and biological
replicates, in one representative somatic tissue; together,
these experiments capture multiple layers of functional
information.
We performed 55 ChIP reactions on a single 96-well
plate plus matched sonicated DNA controls. We usedFigure 1 Schematic of automatic high throughput ChIP-seq protocol
treated with formaldehyde to crosslink protein-DNA contacts. Sonicated lys
to prepared antibody-bound magnetic beads. Wash steps and purification
place on separate automated liquid handling system (Beckman) with subsequ
browser: a 10 kb region surrounding the Ets2 gene on mouse chromosome 1
H3K4me3. Tracks with a blue background highlight data acquired from our o
background highlight AHT-ChIP-seq data. The height of each track (y-axis) co
the RefSeq genome annotation.five individual mouse livers, each of which was used to
generate technical triplicate ChIP experiments for CEBPA
and HNF4A; duplicate ChIPs of RAD21 and p300; and
singlicate ChIPs of H3K4me3. The ChIP-enriched DNA
was then used to create multiplexed libraries for Illumina
sequencing reactions (see Materials and Methods), followed
by paired-end sequencing on a HiSeq2000 with read length
of 75 bp. Reads passing quality control were aligned to the
mouse genome (NCBI mm9) using BWA version 0.6.1 [16]
(Table S1 in Additional file 4). Aligned data from our
own previously published manual data sets [17,18] dis-
played a high degree of correspondence with AHT-
ChIP-seq libraries (Figure 1B) as further detailed below.
These three manual experiments were selected as theand representative data. (A) Primary tissues were isolated and
ate was then transferred to an Agilent workstation where it was added
took place on the Agilent workstation. Illumina library preparation took
ent HiSeq2000 sequencing. (B) Representation from the UCSC genome
6. DNA binding regions for three factors are shown: CEBPA, RAD21 and
wn previously published manual ChIP-seq experiments. Tracks with green
rresponds with uncorrected read depth. Beneath the enrichment track is
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experiments available in our laboratory.
First, we directly compared the 15 ChIP-seq replicates
of CEBPA obtained using the robot with three CEBPA
ChIP-seq experiments our laboratory had previously gen-
erated manually (as detailed above). Regions of enrich-
ment for CEBPA-bound DNA were identified in the three
manual ChIP-seq experiments and our 15 AHT-ChIP-seq
by the peak calling algorithm MACS [19].
As an initial quality control of our ChIP libraries, we
performed a cross-correlation analysis to confirm the qual-
ity of the ChIP experiments, as has been implemented
by the ENCODE consortia [20]. A high-quality ChIP-
seq experiment affords a high density of sequencing tags
directly surrounding the protein-DNA contact location,
which accumulate on both the forward and reverse strands
centered around the binding site. By contrast, ChIP-seq
experiments with poor ChIP enrichment lack these fea-
tures, and instead show variable and dispersed distribu-
tion of reads across the genome. Further, in poor quality
experiments, a phantom peak can be observed when
performing cross-correlation analysis, which corresponds
with read length. Use of this cross-correlation metric con-
firmed that 13 out of our 15 CEBPA AHT-ChIP-seq reac-
tions were extremely high quality, and identified two ChIP
experiments as lower quality, both from a single mouse
(Mmu3), which presented non-specific peaks (Figure S3 in
Additional file 1).
We identified the complete, unified set of genomic
regions bound by any one or more of the ChIP experi-
ments for both the manual (three replicates) and auto-
mated (15 replicates) protocols. We found that the vast
majority of CEBPA-bound regions (peaks) identified by
the manual protocol were captured by at least one ex-
periment in the automated protocol, and vice versa
(Figure 2A): almost 80,000 binding sites were shared.
We next asked what sources of experimental variation
contribute to inter-replicate differences in the complete
set of CEBPA ChIP experiments. By performing a prin-
cipal component analysis, utilizing both the genomic
intervals (peaks) and aligned reads, we observed a high
degree of correspondence between 13 of our AHT-ChIP-
seq CEBPA experiments (Figure 2B). The two outliers
obtained using AHT-ChIP-seq were the two lower-
quality ChIP experiments that showed relatively poor
cross-correlation metrics (see above). As might be expected,
the three manual ChIP-seq experiments were segregated
from the AHT experiments; these experiments were
performed at different times by different researchers in
tissues from different mouse litters.
Next, we compared how well technical CEBPA ChIP
replicates within a single mouse compared to each other.
As a reference, we used the three biological replicate
experiments performed manually. On average, the AHT-ChIP-seq CEBPA derived experiments identified 27,000
binding sites common to each biological replicate
(Figure S4 in Additional file 1). To evaluate the repro-
ducibility of peak calls within our five biological replicates,
we used the overlap rate function in the R/Bioconductor
DiffBind package [11] (Figure S5 in Additional file 1). In
summary, CEBPA-bound intervals were consolidated into
union sets for each independent mouse liver; we then
asked how many peaks from this union set occurred
within increasing numbers of replicates. The degree of
overlap among peak-sets for two replicates was about
60% and 40% among three replicates. By this measure,
the level of overlap demonstrated that technical repro-
ducibility between matched mouse livers done under
exacting conditions was at least equal to experiments
carried out using standard manual methods on three
separate biological samples.
To further evaluate the effectiveness of our AHT-ChIP-
seq method, taking a similar approach to [20], we cal-
culated a simple score for ChIP enrichment as the
percentage of aligned reads located within identified
peak intervals. We established a benchmark set of gen-
omic intervals bound with high confidence by CEBPA
in all three previously published manual ChIP experi-
ments (n = 46,664; median length = 634 bp) (Figure S4
in Additional file 1). We next calculated the propor-
tion of aligned reads that intersected this benchmark
set by randomly sampling five million reads from each
of our 15 AHT-ChIP-seq and the three manual ChIP-
seq experiments, as well as sonicated input DNA con-
trol. Using BedTools and controlling for input DNA [21],
we identified the fraction of aligned reads located within
the benchmark set. There was a high degree of correlation
(Pearson r2 = 0.79) between the ChIP enrichment score
and the number of identified peaks for each replicate
(Figure 2C).
The overall quality of robotic reactions was very high,
with half the automated replicates comparable to the
manual method by these measures, although the ChIP
enrichment score for the manual method was modestly
higher than the AHT-ChIP-seq method, likely due to the
larger amount of tissue and antisera used in manual ChIP
reactions. Because there was little correlation between
sequencing depth and the number of CEBPA-bound
regions identified (Figure 2D), sequencing depth did
not appear to limit our ability to capture ChIP-enriched
regions. The two exceptions were the lower-quality exper-
iments, (Mmu3_r2 and Mmu3_r3) mentioned above:
both were under-represented in their sequencing pools
(approximately six million aligned reads) and had the
least number of peaks identified by MACS peak calling.
We calculated the fraction of peaks that occurred in
one, two, or three-or-more of the 15 AHT replicates
(Figure 2E). In every ChIP-seq experiment, the vast majority
Figure 2 Comparison of inter-replicate data including our own previously published manual ChIP-seq datasets for CEBPA. (A) Proportional
Venn diagram displaying overlap from the union of peak-sets from published manual data and AHT-ChIP-seq for CEBPA. (B) Principal component
analysis with automated ChIP-seq data sets (greens) and manual data set (blue). (C) Scatter plot of percent enrichment (y-axis) versus number of
peaks identified by MACS (x-axis). The Pearson correlation is shown in the upper left corner. AHT-ChIP-seq data sets are indicated in green shades,
and manual data sets in blue. (D) Scatter plot of aligned reads from the automated ChIP-seq data (y-axis) versus number of peaks identified by MACS
(x-axis). Pearson correlation in upper left corner. (E) Fraction of unique peaks for each replicate and those that are represented across multiple experiments.
Peaks that occur in only one replicate are shown in red, those that occur in at least two replicates in grey, and those which occur in at least three triplicates
in black. Mmu1 to Mmu5 refer to biologically individual mice (Mus musculus).
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other ChIP experiments; conversely, 5% to 10% were
not found in any other ChIP experiment and were thus
private to a specific experiment. Collected across all 15
ChIP experiments, privately bound regions numbered in
the tens of thousands (Figure 2A).Applying motif analysis to confirm CEBPA-bound regions
The CEBPA-bound genomic intervals were categorized
by how many replicates captured a particular region:
Group I regions were identified in one replicate (n = 41,249),
and Group II occurred in two or more replicates (n =
81,520). For each of our 15 experiments, sequencing
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group II. The group I fraction were ordered by replicate,
from Mmu1_r1 top to Mmu5_r3 bottom (Figure 3A).
The peaks that were identified as unique to each repli-
cate can be clearly seen with little signal across the
other replicates.Figure 3 Many private and low density peaks are real CEBPA binding
window either side of the center of the peak. The data were then split into
one replicate (n = 41,229); Group II (black) contains those peaks that occurr
of replicate unique peaks ordered by Mmu1_r1 unique peaks (top) to Mmu
motif analyses using MEME and NestedMica software were able to determi
determined by MACS) containing a CEBPA motif were calculated across all
window sizes: 50, 100 and 200 bp. These were compared with multiple ite
(D) For the top 1,000 occupied peaks that occur in multiple replicates (black)
(red), both derived consensus motifs were found to be significantly represent
genomic intervals of equal size are shown for comparison (orange).All CEBPA peaks, regardless of whether found in group
I or group II, had characteristics that reflect direct CEBPA
protein binding to a consensus DNA motif. First, the
CEBPA motif was present in almost all bound regions.
De novo motif searches using the MEME-ChIP analysis
suite and NestedMica [31,32] identified a CEBPA consensusevents. (A) Heat map of sequence tag density, a one kilobase pair
two groups, group I (red) contains those peaks that only occurred in
ed in any two replicates (n = 81,520). Group I peaks are the 15 subsets
5_r3 (bottom). Group II peaks are ordered by occupancy. (B) De novo
ne a consensus DNA sequence for CEBPA. (C) Fractions of peaks (as
replicates and within all peaks using NestedMica for three summit
rations of random sequences using the same summit window sizes.
and the bottom 1,000 occupied peaks identified in only one replicate
ed in both bins using CentriMo analysis software. A random set of 1,000
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(Figure 3B). The CEBPA motif was present in 85% of
identified peaks with a summit window size of 200 bp,
65% for window size of 100 bp, and 49% for window size
of 50 bp. By contrast, similar analyses of random genomic
DNA found the CEBPA motif in 35%, 20%, and 12% for
summit window sizes of 200 bp, 100 bp, and 50 bp re-
spectively (Figure 3C). Second, in regions identified as
bound by CEBPA, the motif was consistently found at
the center of the ChIP-enriched region (Figure 3D).
AHT-ChIP-seq can be used to interrogate protein-DNA
binding in cell lines
To estimate the number of cells needed for an automated
ChIP experiment, we performed H3K4me3 ChIP experi-
ments in two cell lines, HepG2 (hepatocellular carcinoma
cell line) and MCF7 (breast cancer cell line), following a
titration curve of cell number. For each cell line, we
mapped enrichment of trimethylation of H3K4 by per-
forming ChIP in duplicate, using 10 million cells as a
maximum down to 100 cells as a minimum, in order-of-
magnitude steps. As before, the ChIP-enriched DNA was
used to create multiplexed libraries that were sequenced
on an Illumina HiSeq2000. Reads passing quality control
were aligned to the human genome (NCBI36.3 genome
build) using BWA [16] (see Additional file 5) and regions
of enrichment for H3K4me3 bound DNA were identified
by the peak calling algorithm MACS [19]. We found a
high degree of overlap between duplicate experiments
when 10 million cells were used (Figure 4A): 17,704 sites
for HepG2 and 15,090 sites for MCF7. There was also
high degree of overlap between duplicates when one
million cells were used, 11,026 for HepG2 and 11,007
for MCF7s, but fewer binding sites overall were found
when compared to 10 million cells (Figure 4B). The
regions identified as enriched for H3K4me3 were not
consistently called by both replicates in cell numbers
below one million, but did show some enrichment when
manually inspected. Finally, AHT-ChIP-seq failed to yield
any H3K4me3 enrichment when only 100 cells were used.
We conclude that for typical human cancer cell lines,
10 million cells is an optimum cell number for use in
an AHT-ChIP-seq experiment, and 1 million should be
regarded as a minimum number for reproducible ChIP
signal (Figure 4A and B).
AHT-ChIP-seq delivers high quality data on a large scale
Finally, we demonstrated how AHT-ChIP-seq can capture
multiple layers of regulatory information in a single
experiment by mapping many types of protein-DNA
contacts simultaneously in primary mouse liver. We
chose factors with diverse regulatory functions and dis-
tinct patterns of binding: the DNA binding transcription
factor HNF4A [22], which is involved in liver function;RAD21 [23,24], a subunit of cohesin involved in double-
strand break repair and chromatid cohesion during mi-
tosis; p300, a non-DNA-binding protein associated with
enhancer activity [25,26] (otherwise known as EP300);
and H3K4me3, a histone modification associated with
transcription start sites of actively transcribed genes [27].
A representative 50 kb region around the non-coding
RNA AK038602 is shown in Figure 5A. Peaks were
identified as before for all our experiments, and all
identified peaks are displayed by correlation heat map
(Figure 5B), classified into distinct functional groups.
The Mmu2_r1 replicate for RAD21 was highlighted as
an outlier by the clustering analysis, and inspection by
genome browser showed this ChIP experiment had very
low enrichment. With the exception of this single RAD21
ChIP experiment, pair-wise analysis revealed a high level
of correspondence between technical replicates for all 20
experiments for p300 and RAD21 (Figures S6 and S7 in
Additional file 1).
Conclusions
To date, most genome-wide characterizations of protein-
DNA contacts (such as transcription factor binding and
histone marks) have been performed manually in small
batches. Recently, liquid handling robotics have been used
to partially automate functional genomics protocols based
on ChIP experiments [8,9].
Here, we have taken a related approach to create a
fully-automated protocol to perform ChIP experiments
in a standardized 96-well format after isolation of nuclei
and sonication. As the robotics basis for our high-
throughput ChIP platform, we selected the Agilent Bravo
NGS workstation due to its flexibility and intuitive soft-
ware. We validated our protocols by comparing multiple
(>15) technical and biological ChIP replicates in detail,
as well as with published data sets for a representative
tissue-specific transcription factor, CEBPA. Our robotics-
produced data were of high-quality and in strong con-
cordance with previous manual experiments. Based on
list price reagents and excluding cost of final sequencing,
it would cost approximately £750 to perform almost 100
ChIP experiments. As the price of next-generation
sequencing is dropping and the capabilities for multi-
plexing several libraries in one lane is increasing, this
protocol will be accessible to increasing numbers of
laboratories.
Our automation has dramatically increased the typical
efficiency of performing ChIP experiments. Manual pro-
tocols demand over four hours of hands-on time to
perform eight ChIP experiments; by contrast, our robotics
protocols require less than two hours of hands-on time to
perform 96 ChIP experiments.
The standard protocol we detail permits the simultaneous
performance of hundreds of ChIP experiments in parallel
Figure 4 Titration to ascertain optimum cell number for use in AHT-ChIP-seq experiments. (A) Proportional Venn diagrams show the
overlap of peaks between duplicate experiments for a titration curve of cell number for H3K4me3 in HepG2 and MCF7 cell lines, with highest cell
number being log107 and the lowest cell number being log103. No ChIP enrichment was observed for less than 1,000 cells. (B) Line graphs
showing percentage peak recovery for titration of cell number, with cell number shown as log10 scale with highest cell number being 10 million.
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Figure 5 AHT-ChIP-seq can be used to simultaneously map multiple levels of transcriptional control. (A) Representation from UCSC
genome browser, a 50 kb region around the non-coding RNA AK038602 on mouse chromosome 16. Data generated by AHT-ChIP-seq for five
DNA binding regions are shown: HNF4A, CEBPA, RAD21, p300 and H3K4me3. The height of each track (y-axis) corresponds with sequence read
depth. Beneath the enrichment track is the RefSeq genome annotation. (B) Correlation heat map based on peak location identified by MACS,
with three layers of annotation: biological replicate (greens), technical replicate identification (greys) and factors: RAD21 (purple), H3K4me3 (red),
HNF4A (blue), p300 (yellow) and CEBPA (black).
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rapidly multiple biological replicates of transcription
factor binding, chromatin state, and cohesin and co-
activator occupancy can be characterized in a primary
mammalian tissue. From cell number titration curves
for AHT-ChIP-seq, we recommend one million cells
as a minimum number for a ChIP experiment, and 10
million as an optimum number.Future applications and possible technical developments
Reducing cell numbers
Access to adequate patient tissues has been a serious
limitation in using functional genomics in the clinic. In
part by optimizing the robot’s liquid handling actions
throughout the protocol to minimize sample losses, we
have modestly reduced the cell numbers needed for a ChIP
experiment when performed not only against histone
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scription factor. Although reducing cell numbers required
for ChIP experiments was not our primary focus, the
protocol we make available here offers an ideal starting point
to optimize clinical genomics experiments to characterize
the small amount of tissue found in typical biopsies.
Further increasing throughput
The protocols we have developed and report here are
functional on any Bravo robot. Agilent offers a 384-well-
adapted Bravo robot, which would immediately increase
productivity using AHT-ChIP-seq by a factor of four.
Reducing hands-on time
The simple addition of a refrigerated reagent carousel
would make our protocol entirely hands-free.
Materials and Methods
Tissue and cell preparation
ChIP-seq and ChIP-quantitative PCR experiments were
performed on liver material isolated from six adult
(three-month-old) C57/BL6 male mice obtained from
Cancer Research UK Institute and the cell lines HepG2
and MCF7. All tissues were treated post mortem and
cells fixed in culture dishes with 1% formaldehyde. The
investigation was approved by the CRUK Cambridge
Institute ethics committee and followed the CRUK
Cambridge Institute guidelines for the use of animals in
experimental studies under the UK Home Office license.
ChIP-seq
ChIP experiments were adapted from those described
previously with modifications to allow for scaling to a
200 μl volume for immunoprecipitation, as opposed to
laboratory standard 3 ml protocol. Cell lysis and sonic-
ation was carried out as previously described [15], with
minor modifications as follows: cell lysates were left
undiluted and the Triton X-100 volume adjusted ap-
propriately. Protocols carried out on the Agilent Bravo
NGS were programmed as a five-step process and the
Agilent Vworks Automated ChIP protocol files are avail-
able in Additional file 3. All incubation and wash steps
were carried out in a Nunc 1.2 ml deep well plate 260251
(Fisher Scientific UK Ltd, Loughborough, UK).
Step 1: Attachment of antibody to Protein G beads.
A 25 μl aliquot of Invitrogen Protein G Dynabeads (Life
Technologies Ltd, Paisley, UK) was washed with 0.5%
BSA/PBS solution followed by addition of 2.5 μg (12.5 μl
at 0.2 μg/μl) of antibody. The plate was sealed and trans-
ferred to 4°C and mixed for a minimum of four hours on
an orbital shaker Grant-bio, PMS1000 (Grant Instruments
Ltd, Cambridge, UK). In this experiment, antibodies
used were CEBPA sc-9314 (Santa Cruz Biotechnology,
Inc. Heidelberg, Germany), HNF4A ARP31946 (AvivaSystems Biology, Corp. San Diego, CA 92121). p300
sc-585 (Santa Cruz Biotechnology Inc.), RAD21 ab992
(Abcam, Cambridge, UK) and H3K4me3 05-1339 (Millipore
Ltd, Watford, UK).
Step 2: Wash and addition of lysate. We again washed
antibody-bound Protein G beads in 0.5% BSA/PBS solu-
tion and added 180 μl of the sonicated lysate to the pre-
pared beads. The plate was returned to a 4°C cold room
for overnight mixing and hybridization.
Step 3: Wash of DNA bound beads. ChIP-DNA-bound
beads were washed for 10 repetitions in 180 μl cold RIPA
solution, transferred to a rigid PCR plate in 50 μl elution
buffer and placed in a 65°C thermal cycler, for a minimum
of five hours to reverse protein-DNA cross-links.
Step 4: Removal of beads, RNase and proteinase K
treatment. We added 50 μl of Tris-EDTA buffer to the
beads to dilute SDS in elution buffer. Next, 2 μl RNase
AM2269 (Life Technologies) was added to eluted ChIP-
DNA and incubated on Bravo deck at 37°C for 30 minutes,
followed by 2 μl of proteinase K treatment AM2548 (Life
Technologies) at 55°C for one to two hours.
Step 5: Purification of DNA. Phenol and ethanol pre-
cipitation was replaced with an Ampure Bead A63881
(Beckman Coulter Ltd, High Wycombe, UK) cleanup step.
We added 180 μl of beads (1.8 times volume) to the DNA,
followed by two 70% ethanol washes. After the DNA was
eluted in 50 μl water or similar elution buffer, it was ready
for the Illumina library preparation step.
Library and sequencing preparation
Illumina sequencing libraries were prepared from ChIP-
enriched DNA in 96-well microtiter plates using auto-
mated liquid handling robotic platforms. Pre-PCR library
preparation steps were carried out using a Beckman Fxp
dual arm instrument with a Cytomat Microplate Hotel
(Beckman Coulter Ltd) (for method see Figure S8 in
Additional file 1 and Additional file 6). Briefly, 50 μl of
DNA was purified by binding to twice the volume of
AMPure XP beads (Beckman Coulter Ltd) and eluted in
30 μl of 10 mM Tris-HCl, pH 8.5. End-repair, A-tailing
and paired-end adapter ligation were performed using
NEBnext reagents E6000S (New England Biolabs, Hitchin,
UK), with purification using a 1:1 ratio of AMPure XP to
sample between each reaction. Illumina paired-end adapters
were used at a final concentration of 20 pM (a 1:20 dilution
of our standard library adapter concentration) to reduce
adapter dimer formation. After ligation, excess adapters
and adapter dimers were removed using two Ampure
XP cleanups, first with a 0.7:1 ratio of standard Ampure
XP to sample, followed by a 1:1 ratio, with elution in
30 μl of 10 mM Tris-HCl, pH 8.5. We then used 10 μl of
this adapter ligated material as a template for PCR amp-
lification with Kapa HiFi 2x Mastermix KK2602 (Kapa
Biosystems, Inc. Woburn, MA 01801, US) with 200 nM
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plexing PE2.0 primers (see Table S2 in Additional file 7).
After PCR setup on the Beckman Fxp, PCR reactions
were cycled on an MJ Tetrad thermal cycler with the
following conditions: 94°C for 2 minutes; 18 cycles of
94°C for 20 seconds, 65°C for 30 seconds, 72°C for
30 seconds; and 72°C for 3 minutes.
After PCR, excess primers and any primer dimers were
removed by performing a 0.7:1 Ampure XP cleanup on a
Caliper Zephyr liquid handler (Perkin Elmer, Waltham,
MA 02451, USA) with elution in 30 μl of 10 mM Tris-HCl,
pH 8.5. Libraries were pooled in equal volume and the
concentration of that pool determined by real-time PCR
using the SYBR Fast Illumina Library Quantification Kit
(Kapa Biosystems, Inc.) before sequencing on an Illumina
MiSeq, 50 cycles single end plus index read, to determine
the relative representation of each barcoded library. Based
on this data the library pool was reblended so as to give
equal representation of each library, and requantified by
real-time PCR as above, before sequencing on an Illumina
HiSeq 2000 for 75 cycles paired end, plus index read.
Real-time PCR
Evaluation of ChIP enrichment by quantitative real-time
PCR was performed using an ABI7900-HT system as per
manufacturer’s instructions (Life Technologies). Reactions
were performed using Power SYBR Mastermix (Life Tech-
nologies). Samples were normalized to a standard curve
of sonicated input DNA over negative control regions.
Primers used can be found in Table S3 in Additional file 8.
Read mapping and sequencing data analysis
Reads were aligned to reference genome mouse build
(NCBI mm9) or human NCBI36.3 genome build using
BWA version 0.6.1 using default parameters. Ambiguous
reads that mapped to more than one region in the genome
and those with a mapping score of zero were removed.
Regions of ChIP enrichment (peaks) were identified using
MACS [19] versions 1.3.7.1 and 1.4.2 against a matched
input DNA control of similar read depth.
Intersection and pair-wise comparison of data sets was
carried out using Galaxy server [28]. Obtaining counts
within intervals was performed using BedTools within
the Galaxy server [21].
Principal component analysis, peak overlap rates, deter-
mining peak occupancy and peak clustering were all car-
ried out using functions of the R/Bioconductor package
DiffBind version 1.4.2 [29].
Heat maps were created using the SeqMINER pack-
age [30].
De novo motif analysis was carried out using the MEME-
ChIP analysis suite and NestedMica. To assess signifi-
cance of enrichment for CEBPA motifs, NestedMica
[31,32] was used to detect motifs in whole peaks. Eachreplicate was compared to a null distribution generated
from 1,000 sets of random intervals with the same width
distribution. In each case the observed enrichment was
highly significant (Wilcoxon test P <0.001). The overall
significance of enrichment across all replicates was
calculated using a Wilcoxon test comparing the observed
motif content to that expected based on the modes of the
null distributions. CentriMo [33] was used to calculate
the significance of CEBPA motif within a region 200 bp
to either side of the peak summit. Peak summits were
obtained from the output provided by MACS. Random
intervals were obtained using RSAT analysis suite [34].
Proportional Venn diagrams were created using Bio-
Venn [35].
Accession code
Data sets are available from ArrayExpress under the
accession number: E-MTAB-1579, previously published
data sets taken from E-MTAB-941 and E-MTAB-1414.
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Additional file 1: Supplementary Figures 1-8.
Additional file 2: Optimized and final settings for Agilent Bravo
AHT-ChIP protocol.
Additional file 3: Agilent file for automated ChIP method.
Additional file 4: Table S1. MetaData, sequencing metrics, peak calls,
file information for liver experiments.
Additional file 5: MetaData, sequencing metrics, peak calls, file
information for cell-line experiments.
Additional file 6: Beckman. BMF file for Illumina library preparation method.
Additional file 7: Table S2. Illumina library oligonucleotide sequences.
Additional file 8: Table S3. Primer sequences used in ChIP real-time PCR.
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